Multimorbidity: the case for prevention
- PMID: 33020144
- PMCID: PMC7892394
- DOI: 10.1136/jech-2020-214301
Multimorbidity: the case for prevention
Abstract
Multimorbidity is of increasing concern for healthcare systems globally, particularly in the context of ageing population structures, such as in the European Union and the UK. Although there is growing attention on developing strategies to manage the health and healthcare burden of older patients with multimorbidity, little research or policy focus has been placed on how to best prevent the development of multimorbidity in future generations. In this research agenda piece, we argue for a shift from a sole focus on the management of multimorbidity in old age to a multimorbidity agenda that considers prevention and management throughout the life-course.
Keywords: Epidemiology of chronic diseases; Prevention; Public health.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: AH, KF, CK and MOF report no competing interests. JP-S is vice-chairman of the Royal Society for Public Health and reports personal fees from Novo Nordisk A/S and Lane, Clark & Peacock LLP outside of the submitted work.
References
-
- WHO Multimorbidity: technical series on safer primary care. World Health Organization. 2016.
-
- The Academy of Medical Sciences Multimorbidity: a priority for global health research. 2018.
-
- Department of Health and Social Care Annual report of the chief medical officer, 2018: health 2040: better health within reach. Department of Health and Social Care; 2018.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical